超声引导下网膜活检:18年单中心系列诊断率及与CT特征关联
该回顾性单中心研究纳入163例接受超声引导下网膜活检的患者,评估诊断率并探索其与活检前CT表现的关系。结果显示活检诊断率为95%,与CT上网膜病变呈浸润型或肿块型、超声回声高低及网膜厚度等均无显著关联,且无并发症发生,支持超声作为网膜活检的一线引导方式。
要点
- 超声引导下网膜活检诊断率高达95%,无并发症,安全有效。
- CT显示网膜病变呈浸润型或肿块型不影响超声引导活检的诊断率。
- 超声上病灶低回声或等-高回声对诊断率无显著影响。
关键影像表现/征象
- 活检前CT显示网膜病变呈浸润型127例(78%),肿块型36例(22%)。
- 超声上病灶呈低回声105例(64%),等-高回声58例(36%)。
- CT上活检部位附近网膜平均厚度为2.6±1.2 cm。
诊断标准与关键数值
- 超声引导下网膜活检总体诊断率为95%(155/163)。
临床应用与阅片要点
- 超声可作为网膜活检的首选引导方式,尤其适合有CT定位标志的弥漫浸润病变。
- 即使超声未见明确肿块,仅见弥漫增厚,也可依据CT标志进行取样。
- 操作可由腹部放射科医生完成,无需介入放射专科培训。
局限性
- 回顾性单中心设计,可能存在选择偏倚。
- 样本以恶性肿瘤为主(95%),良性病变占6%,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. The greater omentum can serve as a useful target for percutaneous biopsy; in clinical practice, CT is commonly used for biopsy guidance. OBJECTIVE. The purpose of this study was to evaluate the diagnostic yield of percutaneous ultrasound (US)-guided omental biopsy and to explore the association of the diagnostic yield with prebiopsy diagnostic CT findings. METHODS. This retrospective study included 163 patients (120 women and 43 men; mean age, 65 ± 12 [SD] years; mean body mass index [BMI], 28.9 ± 7.9) who underwent US-guided omental biopsy between 2002 and 2020 at a single institution at which US served as the first-line modality for omental biopsy guidance. Biopsies were performed by abdominal radiologists without dedicated interventional radiology fellowship training. Postbiopsy clinical follow-up and imaging follow-up were reviewed to establish the ultimate diagnosis for each patient. Omental biopsies were characterized as diagnostic or nondiagnostic relative to the ultimate diagnosis. Associations were explored between diagnostic yield and findings on prebiopsy CT and biopsy US. RESULTS. US-guided omental biopsy was performed using an 18-gauge core needle biopsy technique in 156 patients and fine-needle aspiration in seven patients. The mean number of biopsy passes was 2.5 ± 1.0, and mean omental thickness near the biopsy site on CT was 2.6 ± 1.2 cm. On prebiopsy diagnostic CT, omental disease appeared infiltrative in 127 (78%) patients versus mass-forming in 36 (22%) and appeared hypoechoic in 105 (64%) patients versus iso- to hyperechoic in 58 (36%). The ultimate diagnosis was malignant tumor in 154 (95%) patients (most commonly, gynecologic tumors in 82 patients [high-grade serous adenocarcinoma in 56] and gastrointestinal tumors in 45 patients) and a benign finding in nine (6%) patients. The omental biopsy was diagnostic relative to the ultimate diagnosis in 155 (95%) patients. A diagnostic versus nondiagnostic biopsy was not associated (p > .05) with age, BMI, number of biopsy passes, or omental target thickness or attenuation. A total of 94% (120/127) of US-guided omental biopsies of infiltrative cases and 97% (35/36) of biopsies of mass-forming cases were diagnostic (p = .50). A total of 96% (102/106) of US-guided omental biopsies of hypoechoic cases and 93% (53/57) of biopsies of iso- to hyperechoic cases were diagnostic (p = .36). No complications occurred. CONCLUSION. US-guided biopsy of omental disease suspected on CT is safe and effective for tissue diagnosis. Although omental disease commonly appears on US as diffuse infiltrative thickening without a discrete target, sampling based on prebiopsy CT landmarks is diagnostic in most cases. CLINICAL IMPACT. US should be considered the first-line modality for omental biopsy guidance when feasible.
引用
- Perez AA, Lubner MG, Pickhardt PJ, et al. Ultrasound-Guided Omental Biopsy: Diagnostic Yield and Association With CT Features Based on a Single-Institution 18-Year Series. AJR Am J Roentgenol. 2021. PMID: 33852358. doi:10.2214/AJR.21.25545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。